Items where Author is "Wernli, M."

Article

Hehlmann, R. and Lauseker, M. and Saussele, S. and Pfirrmann, M. and Krause, S. and Kolb, H. J. and Neubauer, A. and Hossfeld, D. K. and Nerl, C. and Gratwohl, A. and Baerlocher, G. M. and Heim, D. and Bruemmendorf, T. H. and Fabarius, A. and Haferlach, C. and Schlegelberger, B. and Mueller, M. C. and Jeromin, S. and Proetel, U. and Kohlbrenner, K. and Voskanyan, A. and Rinaldetti, S. and Seifarth, W. and Spiess, B. and Balleisen, L. and Goebeler, M. C. and Haenel, M. and Ho, A. and Dengler, J. and Falge, C. and Kanz, L. and Kremers, S. and Burchert, A. and Kneba, M. and Stegelmann, F. and Koehne, C. A. and Lindemann, H. W. and Waller, C. F. and Pfreundschuh, M. and Spiekermann, K. and Berdel, W. E. and Mueller, L. and Edinger, M. and Mayer, J. and Beelen, D. W. and Bentz, M. and Link, H. and Hertenstein, B. and Fuchs, R. and Wernli, M. and Schlegel, F. and Schlag, R. and de Wit, M. and Truemper, L. and Hebart, H. and Hahn, M. and Thomalla, J. and Scheid, C. and Schafhausen, P. and Verbeek, W. and Eckart, M. J. and Gassmann, W. and Pezzutto, A. and Schenk, M. and Brossart, P. and Geer, T. and Bildat, S. and Schaefer, E. and Hochhaus, A. and Hasford, J. (2017) Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants. LEUKEMIA, 31 (11). pp. 2398-2406. ISSN 0887-6924, 1476-5551